Trial intelligence / Profile preview

Anesthetic Efficacy of Articaine, Mepivacaine, and Lidocaine for IANB in Irreversible Pulpitis

NCT05239078Completed

Start
Mar 2016
Primary completion
Feb 2017
Modality
Small Molecules
01

Overview

Randomised, double-blind trial of articaine and mepivacaine in irreversible pulpitis (3 arms). Primary endpoint: Anesthetic Success at 15 minutes. Started Mar 2016; status: completed.

02

Drugs

articainemepivacaine
03

Conditions

irreversible pulpitis

Beyond the preview

Go deeper on NCT05239078.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05239078.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call